T1	CHEM 219 222	FOS
#1	AnnotatorNotes T1	C0873033; fructooligosaccharide; Organic Chemical · Pharmacologic Substance
T2	PROC 1 62	Ensayo clínico aletorizado doble ciego controlado con placebo
#2	AnnotatorNotes T2	C0206034; Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product
T3	CHEM 94 114	ácido alfa linoleico
#3	AnnotatorNotes T3	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T4	CHEM 117 128	prebióticos
#4	AnnotatorNotes T4	C2717875; Prebiotics; Organic Chemical
T5	ANAT 152 166	cardiovascular
#5	AnnotatorNotes T5	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T6	DISO 180 186	obesos
#6	AnnotatorNotes T6	C0028754; Obesity; Disease or Syndrome
T7	CHEM 303 324	acido alfa linolénico
#7	AnnotatorNotes T7	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T8	CHEM 205 212	inulina
#8	AnnotatorNotes T8	C0021936; inulin; Organic Chemical · Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T9	CHEM 227 238	prebióticos
#9	AnnotatorNotes T9	C2717875; Prebiotics; Organic Chemical
T10	ANAT 284 298	cardiovascular
#10	AnnotatorNotes T10	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T11	CHEM 326 329	ALA
#11	AnnotatorNotes T11	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T12	DISO 498 519	riesgo cardiovascular
#12	AnnotatorNotes T12	C4324389; Cardiovascular Risk; Finding
T13	CHEM 351 374	ácido eicosapentaenoico
#13	AnnotatorNotes T13	C0000545; eicosapentaenoic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T14	PROC 673 685	randomizados
#14	AnnotatorNotes T14	C0034656; Randomization; Research Activity
T15	ANAT 505 519	cardiovascular
#15	AnnotatorNotes T15	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T16	DISO 533 539	obesos
#16	AnnotatorNotes T16	C0028754; Obesity; Disease or Syndrome
T17	CHEM 600 607	inulina
#17	AnnotatorNotes T17	C0021936; inulin; Organic Chemical · Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T18	CHEM 615 618	ALA
#18	AnnotatorNotes T18	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T19	CHEM 744 751	inulina
#19	AnnotatorNotes T19	C0021936; inulin; Organic Chemical · Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T20	CHEM 759 762	ALA
#20	AnnotatorNotes T20	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T21	CHEM 1195 1198	FOS
#21	AnnotatorNotes T21	C0873033; fructooligosaccharide; Organic Chemical · Pharmacologic Substance
T22	PROC 905 916	tratamiento
#22	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 942 964	valoración nutricional
#23	AnnotatorNotes T23	C0028708; Nutrition Assessment; Diagnostic Procedure
T24	PROC 967 976	analítica
#24	AnnotatorNotes T24	C0002778; Analysis of substances; Laboratory Procedure | C0814047; biological analysis and measurement; Laboratory Procedure
T25	PROC 1006 1015	protocolo
#25	AnnotatorNotes T25	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T26	ANAT 1817 1833	gastrointestinal
#26	AnnotatorNotes T26	C0012240; Gastrointestinal system; Body System
T27	CHEM 1123 1128	fibra
#27	AnnotatorNotes T27	C0225326; fiber; Organic Chemical · Pharmacologic Substance
T28	CHEM 1185 1192	inulina
#28	AnnotatorNotes T28	C0021936; inulin; Organic Chemical · Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T29	CHEM 1210 1213	ALA
#29	AnnotatorNotes T29	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T30	CHEM 1387 1397	colesterol
#30	AnnotatorNotes T30	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T31	PROC 1458 1472	LDL colesterol
#31	AnnotatorNotes T31	C0428474; Serum LDL cholesterol measurement; Laboratory Procedure
T32	PROC 1528 1547	proteína C reactiva
#32	AnnotatorNotes T32	C0201657; C-reactive protein measurement; Laboratory Procedure
T33	CHEM 1946 1949	FOS
#33	AnnotatorNotes T33	C0873033; fructooligosaccharide; Organic Chemical · Pharmacologic Substance
T34	CHEM 1726 1731	fibra
#34	AnnotatorNotes T34	C0225326; fiber; Organic Chemical · Pharmacologic Substance
T35	CHEM 1742 1745	ALA
#35	AnnotatorNotes T35	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T36	DISO 1791 1833	efecto secundario a nivel gastrointestinal
#36	AnnotatorNotes T36	C0421220; Gastrointestinal tract drug side effect; Finding
T37	CHEM 1923 1930	inulina
#37	AnnotatorNotes T37	C0021936; inulin; Organic Chemical · Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T38	CHEM 1966 1969	ALA
#38	AnnotatorNotes T38	C0051405; alpha-Linolenic Acid; Biologically Active Substance · Organic Chemical
T39	DISO 1995 2001	obesos
#39	AnnotatorNotes T39	C0028754; Obesity; Disease or Syndrome
T40	CHEM 2025 2035	colesterol
#40	AnnotatorNotes T40	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T41	PROC 2043 2057	LDL colesterol
#41	AnnotatorNotes T41	C0428474; Serum LDL cholesterol measurement; Laboratory Procedure
T42	PROC 2060 2079	proteína C reactiva
#42	AnnotatorNotes T42	C0201657; C-reactive protein measurement; Laboratory Procedure
T43	DISO 145 166	riesgo cardiovascular
#43	AnnotatorNotes T43	C4324389; Cardiovascular Risk; Finding
T44	CHEM 609 612	FOS
#44	AnnotatorNotes T44	C0873033; fructooligosaccharide; Organic Chemical · Pharmacologic Substance
T45	CHEM 376 384	20: 5n-3
#45	AnnotatorNotes T45	C0000545; eicosapentaenoic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T46	CHEM 753 756	FOS
#46	AnnotatorNotes T46	C0873033; fructooligosaccharide; Organic Chemical · Pharmacologic Substance
T47	PROC 564 569	dieta
#47	AnnotatorNotes T47	C1519433; Special Diet Therapy; Therapeutic or Preventive Procedure
T48	PROC 1376 1403	niveles de colesterol total
#48	AnnotatorNotes T48	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T49	PROC 2014 2041	niveles de colesterol total
#49	AnnotatorNotes T49	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T51	LIVB 170 179	pacientes
#50	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T54	LIVB 523 532	pacientes
#51	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 656 665	pacientes
#52	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 813 821	paciente
#53	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Frequency 853 859	al día
T59	Duration 922 925	mes
T60	LIVB 1031 1040	pacientes
#54	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Dose 1138 1149	2,3 ± 0,8 g
T62	Frequency 1149 1153	/día
T63	Dose 1157 1168	7,7 ± 0,8 g
T64	Frequency 1168 1172	/día
T65	Dose 1215 1226	0,6 ± 0,5 g
T66	Frequency 1226 1230	/día
T67	Dose 1234 1245	3,8 ± 0,5 g
T68	Frequency 1245 1249	/día
T69	LIVB 1280 1297	pacientes varones
#55	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group
T77	LIVB 1753 1762	pacientes
#56	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T79	Neg_cue 1784 1790	ningún
T80	Dose 1904 1912	2 gramos
T81	Frequency 1913 1919	al día
T82	Dose 1932 1942	3,1 gramos
T83	Dose 1952 1962	3,2 gramos
T84	LIVB 1985 1994;2002 2009	pacientes varones
#57	AnnotatorNotes T84	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group
T50	PHYS 411 427	antinflamatorias
#58	AnnotatorNotes T50	C1516019; Antiinflammatory Effect; Physiologic Function
T53	PHYS 1705 1712	ingesta
#59	AnnotatorNotes T53	C0232478; Ingestion; Biologic Function
T58	PHYS 1865 1872	ingesta
#60	AnnotatorNotes T58	C0232478; Ingestion; Biologic Function
T70	PHYS 1112 1119	ingesta
#61	AnnotatorNotes T70	C0232478; Ingestion; Biologic Function
A1	Assertion T36 Negated
T52	Neg_cue 1596 1598	No
T71	CONC 1610 1621	diferencias
A2	Assertion T71 Negated
#62	AnnotatorNotes T71	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T52 Arg2:T71	
R2	Negation Arg1:T79 Arg2:T36	
R3	Location_of Arg1:T26 Arg2:T36	
T72	Spec_cue 243 254	potenciales
T73	Observation 255 275	efectos beneficiosos
A3	Assertion T73 Speculated
#63	AnnotatorNotes T73	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R4	Combined_with Arg1:T3 Arg2:T4	
R5	Location_of Arg1:T5 Arg2:T43	
R6	Experiences Arg1:T51 Arg2:T6	
R7	Experiences Arg1:T51 Arg2:T43	
R8	Overlap Arg1:T43 Arg2:T6	
T74	Food 71 78	galleta
#64	AnnotatorNotes T74	C3853210; Cookie; Food
R9	Combined_with Arg1:T74 Arg2:T3	
R10	Experiences Arg1:T51 Arg2:T74	
R11	Speculation Arg1:T72 Arg2:T73	
R12	Location_of Arg1:T10 Arg2:T73	
R13	Before Arg1:T8 Arg2:T73	
R14	Before Arg1:T9 Arg2:T73	
R15	Before Arg1:T1 Arg2:T73	
R16	Causes Arg1:T11 Arg2:T50	
R17	Causes Arg1:T7 Arg2:T50	
R18	Location_of Arg1:T15 Arg2:T12	
R19	Overlap Arg1:T12 Arg2:T16	
R20	Experiences Arg1:T54 Arg2:T12	
R21	Experiences Arg1:T54 Arg2:T16	
R22	Experiences Arg1:T54 Arg2:T47	
T75	Food 577 584	galleta
#65	AnnotatorNotes T75	C3853210; Cookie; Food
R23	Used_for Arg1:T75 Arg2:T47	
R24	Combined_with Arg1:T75 Arg2:T17	
R25	Combined_with Arg1:T17 Arg2:T44	
R26	Combined_with Arg1:T44 Arg2:T18	
T76	Observation 474 483	respuesta
#66	AnnotatorNotes T76	C4055223; Clinical Response; Finding (?)
R27	Experiences Arg1:T54 Arg2:T76	
R28	After Arg1:T76 Arg2:T47	
T78	Food 717 724	galleta
#67	AnnotatorNotes T78	C3853210; Cookie; Food
R29	Combined_with Arg1:T78 Arg2:T19	
R30	Combined_with Arg1:T19 Arg2:T46	
R31	Combined_with Arg1:T46 Arg2:T20	
R32	Before Arg1:T14 Arg2:T78	
R33	Experiences Arg1:T55 Arg2:T19	
T85	Food 766 773	galleta
#68	AnnotatorNotes T85	C3853210; Cookie; Food
T86	Food 778 785	galleta
#69	AnnotatorNotes T86	C3853210; Cookie; Food
R34	Experiences Arg1:T55 Arg2:T85	
R35	Experiences Arg1:T55 Arg2:T86	
T87	Quantifier_or_Qualifier 786 793	control
#70	AnnotatorNotes T87	C4553389; Study Control; Conceptual Entity
R36	Has_Quantifier_or_Qualifier Arg1:T86 Arg2:T87	
R37	Before Arg1:T14 Arg2:T85	
R38	Before Arg1:T14 Arg2:T86	
T88	Food 844 852	galletas
#71	AnnotatorNotes T88	C3853210; Cookie; Food
R39	Has_Frequency Arg1:T88 Arg2:T57	
T89	Quantifier_or_Qualifier 842 843	2
R40	Has_Quantifier_or_Qualifier Arg1:T88 Arg2:T89	
R41	Experiences Arg1:T56 Arg2:T88	
T90	Result_or_Value 861 870	70 gramos
R42	Has_Result_or_Value Arg1:T88 Arg2:T90	
R43	Before Arg1:T23 Arg2:T22	
R44	Before Arg1:T24 Arg2:T22	
R45	After Arg1:T23 Arg2:T59	
R46	After Arg1:T24 Arg2:T59	
T91	Observation 991 1015	Finalizaron el protocolo
#72	AnnotatorNotes T91	C0580352; Treatment completed; Finding (?)
R47	Experiences Arg1:T60 Arg2:T91	
T92	Observation 1084 1091;1106 1119	aumento en la ingesta
R48	Used_for Arg1:T27 Arg2:T70	
T93	Quantifier_or_Qualifier 1129 1136	soluble
#73	AnnotatorNotes T93	C1948047; Soluble (qualifier); Qualitative Concept
R50	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T93	
R51	Has_Dose_or_Strength Arg1:T27 Arg2:T61	
R52	Has_Frequency Arg1:T27 Arg2:T62	
R53	Has_Dose_or_Strength Arg1:T27 Arg2:T63	
R54	Has_Frequency Arg1:T27 Arg2:T64	
R55	Combined_with Arg1:T28 Arg2:T21	
R56	Has_Frequency Arg1:T28 Arg2:T64	
R57	Has_Frequency Arg1:T21 Arg2:T64	
R58	Has_Dose_or_Strength Arg1:T28 Arg2:T63	
R59	Has_Dose_or_Strength Arg1:T21 Arg2:T63	
R60	Has_Dose_or_Strength Arg1:T28 Arg2:T61	
R61	Has_Dose_or_Strength Arg1:T21 Arg2:T61	
R62	Has_Frequency Arg1:T28 Arg2:T62	
R63	Has_Frequency Arg1:T21 Arg2:T62	
R64	Combined_with Arg1:T27 Arg2:T29	
R65	Has_Dose_or_Strength Arg1:T29 Arg2:T65	
R66	Has_Dose_or_Strength Arg1:T29 Arg2:T67	
R67	Has_Frequency Arg1:T29 Arg2:T66	
R68	Has_Frequency Arg1:T29 Arg2:T68	
T94	Food 1317 1325	galletas
#74	AnnotatorNotes T94	C3853210; Cookie; Food
R69	Experiences Arg1:T69 Arg2:T94	
T95	Observation 1343 1354;1369 1403	disminución de los niveles de colesterol total
#75	AnnotatorNotes T95	C0860921; Cholesterol total decreased; Finding
R70	Experiences Arg1:T69 Arg2:T95	
R71	Before Arg1:T94 Arg2:T95	
T96	Observation 1343 1354;1369 1371;1458 1472	disminución de LDL colesterol
#76	AnnotatorNotes T96	C0853085; Decreased LDL cholesterol concentration; Finding 
R72	Experiences Arg1:T69 Arg2:T96	
T97	Observation 1343 1354;1369 1371;1528 1547	disminución de proteína C reactiva
#77	AnnotatorNotes T97	C0877451; C-reactive protein decreased; Finding
R73	Experiences Arg1:T69 Arg2:T97	
R74	Experiences Arg1:T69 Arg2:T31	
R75	Experiences Arg1:T69 Arg2:T32	
R76	Experiences Arg1:T69 Arg2:T48	
R77	Before Arg1:T94 Arg2:T96	
R78	Before Arg1:T94 Arg2:T97	
T98	Quantifier_or_Qualifier 1622 1653	estadísticamente significativas
A4	Assertion T98 Negated
#78	AnnotatorNotes T98	C0237881; Statistical Significance; Quantitative Concept
R79	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T98	
R80	Negation Arg1:T52 Arg2:T98	
T99	CONC 1661 1686	variables antropométricas
#79	AnnotatorNotes T99	C0815129; anthropometric measurement; Quantitative Concept
T100	Observation 1691 1712	aumento de la ingesta
R82	Used_for Arg1:T34 Arg2:T53	
R83	Combined_with Arg1:T34 Arg2:T35	
R84	Experiences Arg1:T77 Arg2:T34	
R85	Experiences Arg1:T77 Arg2:T53	
R86	Experiences Arg1:T77 Arg2:T100	
T101	Quantifier_or_Qualifier 1732 1739	soluble
#80	AnnotatorNotes T101	C1948047; Soluble (qualifier); Qualitative Concept
R87	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T101	
R88	Experiences Arg1:T77 Arg2:T36	
R89	Before Arg1:T100 Arg2:T36	
R90	Before Arg1:T34 Arg2:T36	
T102	Observation 1851 1872	aumento en la ingesta
T103	Food 1881 1888	galleta
#81	AnnotatorNotes T103	C3853210; Cookie; Food
R91	Combined_with Arg1:T103 Arg2:T37	
R92	Combined_with Arg1:T37 Arg2:T33	
R93	Combined_with Arg1:T33 Arg2:T38	
R94	Has_Dose_or_Strength Arg1:T38 Arg2:T83	
R95	Has_Dose_or_Strength Arg1:T33 Arg2:T82	
R96	Has_Frequency Arg1:T37 Arg2:T81	
R97	Has_Dose_or_Strength Arg1:T37 Arg2:T80	
R98	Used_for Arg1:T103 Arg2:T58	
R100	Experiences Arg1:T84 Arg2:T102	
R101	Experiences Arg1:T84 Arg2:T58	
R102	Experiences Arg1:T84 Arg2:T37	
R103	Experiences Arg1:T84 Arg2:T39	
R104	Experiences Arg1:T84 Arg2:T49	
R105	Experiences Arg1:T84 Arg2:T41	
R106	Experiences Arg1:T84 Arg2:T42	
T104	Observation 1971 1977	mejora
#82	AnnotatorNotes T104	C0184511; Improved; Finding (?)
R107	Experiences Arg1:T84 Arg2:T104	
R108	Causes Arg1:T102 Arg2:T104	
R109	Causes Arg1:T37 Arg2:T104	
R112	Has_Result_or_Value Arg1:T32 Arg2:T97	
#83	AnnotatorNotes T89	C0205448; Two; Quantitative Concept
A5	Experiencer T51 Patient
A6	Experiencer T54 Patient
A7	Experiencer T55 Patient
A8	Experiencer T56 Patient
A9	Experiencer T60 Patient
A10	Experiencer T69 Patient
A11	Experiencer T77 Patient
A12	Experiencer T84 Patient
R49	Has_Result_or_Value Arg1:T48 Arg2:T95	
R81	Has_Result_or_Value Arg1:T31 Arg2:T96	
